P-450-dependent epoxygenase pathway of arachidonic acid and the products of epoxyeicosatrienoic acids（EETs） have been demonstrated to be involved in angiogenesis and tumor progression.This study examined the expression of EETs and the role of the pathway in the angiogenesis of multiple myeloma（MM）.MM cell lines of U266 and RPMI8226 were cultured,and the EETs levels（11,12-EET and 14,15-EET） in the supernatant were determined by ELISA.Human umbilical vein endothelial cells（HUVECs） were cultured and used for analysis of the angiogenesis activity of the two MM cell lines,which was examined both in vitro and in vivo by employing MTT,chemotaxis,tube formation and matrigel plug assays.11,12-EET and 14,15-EET were found in the supernatant of the cultured MM cells.The levels of the two EETs in the supernatant of U266 cells were significantly higher than those in the RPMI8226 cell supernatant（P〈0.05）,and the levels paralleled the respective angiogenesis activity of the two different MM cell lines.17-octadecynoic acid（17-ODYA）,as a specific inhibitor of P450 enzyme,suppressed HUVECs proliferation and tube formation induced by MM cells.Furthermore,17-ODYA decreased the EET levels in the supernatant of MM cells.These results suggest that EETs may play an important role in the angiogenesis of MM,and the inhibitor 17-ODYA suppresses this effect.
